During the last session, Biolife Solutions Inc (NASDAQ:BLFS)’s traded shares were 0.35 million, with the beta value of the company hitting 1.89. At the end of the trading day, the stock’s price was $25.96, reflecting an intraday loss of -0.80% or -$0.21. The 52-week high for the BLFS share is $29.55, that puts it down -13.83 from that peak though still a striking 42.84% gain since the share price plummeted to a 52-week low of $14.84. The company’s market capitalization is $1.22B, and the average intraday trading volume over the past 10 days was 0.31 million shares, and the average trade volume was 292.40K shares over the past three months.
Biolife Solutions Inc (BLFS) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. BLFS has a Sell rating from 0 analyst(s) out of 4 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 4 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.04.
Biolife Solutions Inc (NASDAQ:BLFS) trade information
Biolife Solutions Inc (BLFS) registered a -0.80% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -0.80% in intraday trading to $25.96, hitting a weekly high. The stock’s 5-day price performance is 3.88%, and it has moved by 10.09% in 30 days. Based on these gigs, the overall price performance for the year is 43.43%. The short interest in Biolife Solutions Inc (NASDAQ:BLFS) is 3.47 million shares and it means that shorts have 8.98 day(s) to cover.
The consensus price target of analysts on Wall Street is $30, which implies an increase of 13.47% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $30 and $30 respectively. As a result, BLFS is trading at a discount of -15.56% off the target high and -15.56% off the low.
Biolife Solutions Inc (BLFS) estimates and forecasts
In the rating firms’ projections, revenue will increase 17.96% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 22.22M as predicted by 9 analyst(s). Meanwhile, a consensus of 9 analyst(s) estimates revenue growth to 23.46M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 31.73M and 28.33M respectively. In this case, analysts expect current quarter sales to shrink by -29.96% and then drop by -17.19% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -55.83%. While earnings are projected to return 52.57% in 2025.
BLFS Dividends
Biolife Solutions Inc is due to release its next quarterly earnings on 2025-Mar-02. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Biolife Solutions Inc (NASDAQ:BLFS)’s Major holders
Biolife Solutions Inc insiders own 2.47% of total outstanding shares while institutional holders control 101.80%, with the float percentage being 104.38%. CASDIN CAPITAL, LLC is the largest shareholder of the company, while 266.0 institutions own stock in it. As of 2024-06-30, the company held over 8.71 million shares (or 18.927% of all shares), a total value of $186.59 million in shares.
The next largest institutional holding, with 5.49 million shares, is of BLACKROCK INC.’s that is approximately 11.9296% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $117.61 million.
Also, the Mutual Funds coming in first place with the largest holdings of Biolife Solutions Inc (BLFS) shares are iShares Trust-iShares Core S&P Small-Cap ETF and ALGER FUNDS-Alger Small Cap Focus Fund . Data provided on Feb 28, 2025 indicates that iShares Trust-iShares Core S&P Small-Cap ETF owns about 2.31 shares. This amounts to just over 4.91 percent of the company’s overall shares, with a $59.87 million market value. The same data shows that the other fund manager holds slightly less at 1.41, or about 3.01% of the stock, which is worth about $36.73 million.
